In this study, 45 fatigued patients with multiple sclerosis (MS) were randomly assigned to undergo treatment with fampridine, amantadine or placebo and underwent clinical, neuropsychological and 3T resting state (RS) functional MRI at baseline and after four weeks of treatment. We found that treatment with fampridine (and, to a lesser extent, with amantadine) ameliorates fatigue in MS. Concomitant increase of RS functional connectivity (FC) in inferior frontal and parietal cortical regions, and decrease of abnormally high intra-thalamic FC were detected, suggesting an improved regulation of cortico-subcortical functional circuits.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords